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«They say things are happening at the border, but nobody knows which border» (Mark Strand) 
 
New economic challenges for managing disease prevention 
and monitoring 
by Pablo Collazzo – Mauro Romanelli – Paola Briganti – Paolino Fierro – Davide de 
Gennaro 
Abstract: Managing disease prevention and monitoring its progression benefits professionals facing 
the challenge of acquiring new knowledge and information for fighting the many diseases that 
negatively affect the life of people in areas such as public health systems, families, economic and 
business systems. From economic and operational points of view, Cancer Registries as organisations 
managing information by collecting, storing, reporting and interpreting data to improve cancer 
monitoring which is needed to plan health policies evaluation and design. Sustaining the role of the 
Cancer Registry as information system for fighting against cancer relies on paying attention on 
regulatory and ethical aspects with regard to the protection of confidential data, understanding and 
meeting the organisational challenges, learning from theory and practice emerging from the 
comparison of international experiences, bringing together voluntary, private initiatives of 
associations and public programs for sustaining the relevance of gathering and collecting data, 
information for knowledge about managing prevention and monitoring of the disease as core 
competence for driving public health systems towards sustainable development.Regulatory and 
organizational infrastructures help improve both information and knowledge management and 
design and implement effective measures and initiatives leading to efficacy in preventing and 
monitoring cancer disease as support to medical scientific research for cancer cure. 
 
Summary: 1. Introduction. – 2. Managing disease prevention systems. – 3. Disease registries as 
organisation: regulation and ethical aspects – 4. Managing information and knowledge – 5. 
International experiences and practices – 6. The Airtum as organisational form and coordinating 
mechanism. – 7. A case study for improving the disease prevention and monitoring. – 8. Conclusions. 
 
 
1. Managing disease prevention and monitoring helps professionals facing the challenge of acquiring 
new knowledge and information for fighting against many diseases that negatively affect the lives of 
people in terms of public health systems costs. Cancer Registries as organisation responsible for 
ensuring effective collection, storage, reporting and interpretation of data help to improve cancer 
monitoring and build new knowledge for disease treatment, analysis, prevention and monitoring which 
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can in turn drive improved health policy planning, evaluation and design. The aim of this study is to 
investigate how Cancer Registries may operate as systems for gathering, collecting and managing 
information to create new knowledge base with regards to cancer disease prevention and monitoring. 
The study relies on archival and qualitative data drawn by considering the Cancer Registries as 
organisations and information sources for managing disease prevention, monitoring and control. A 
literature review on the international experiences and practices is presented. Finally, to facilitate the 
study aims, the data gathering and collection concerning the role of the AIRTUM Associazione Italiana 
Registri Tumori as an organisational form for coordinating the activities related to cancer prevention 
and analysis, and the case study represented by the Terra dei Fuochi (The Land of Fires) as laboratory 
and case study highlighting the need to strengthen and improve the Cancer Registries as informational 
sources for knowledge improvement, sharing and creation will be examined. 
The study is organised as follows. Following this introduction, in the second section, some 
considerations on management systems for disease prevention are presented. In the third section, the 
features of Cancer Registries as organisations with regards to regulatory and ethical aspects of the 
treatment of confidential data are presented. In the fourth section, the role of Cancer Registries as 
organisations managing information and knowledge for disease prevention is elucidated. In particular, 
the analysis explores international experiences and practices; to explain the role, the goals and the task 
of AIRTUM as organisational form and mechanism of coordination for the activities related to the 
cancer prevention and monitoring. Also in this section, the Terra dei Fuochi (The Land of Fires) as case 
study is discusses, as an experiment to improve the role and value of Cancer Registries to better manage 
and share information and knowledge for improving the cancer prevention. 
 
 
2. Chronic diseases such as heart conditions, cancer, diabetes, chronic respiratory disease, or visual and 
auditory defects contribute significantly to premature deaths and disabilities, and thus heavily affecting 
the quality of life of individuals[1], particularly those in disadvantaged socio-economic people[2]. 
Generally, the chronic illness originates at an early age, but can take decades before becoming clinically 
apparent, thus requiring long term care. It is at this latter stage that the disease offers the opportunity 
for analysing, studying and finding solutions for prevention and monitoring, and efficacy in its cure. 
Employing medical record systems may lead to major health care savings while improving individuals’ 
health, even if benefits may materialize themselves at a later stage[3] and prevention systems are still 
poorly implemented[4]. 
Prevention systems deal with the continuous monitoring of the distribution and progression of a disease 
incidence in a population through systematic data collection, analysis and evaluation of morbidity, 
mortality and other relevant data, as well as the disclosure of information to everyone who contributed 
to the system and to everyone who needs to know about the issues[5]. 
Monitoring systems allow researchers to classify and categorise diseases to provide a useful overview to 
address these issues and offer results that permit healthcare professionals to develop plans to be 
targeted at specific interventions and to evaluate their effectiveness over time. The international cases 
about general disease prevention systems, structures, methods and techniques encompass a range of 
monitoring and prevention models (epidemiological data collection, analysis, interpretation, prevention 
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initiatives ranging from information and training to the population to specific diagnostic services on the 
territory). 
The automated telephone communication systems (ATCS), unidirectional (one-way, non-interactive 
voice communication), interactive voice response (IVR) systems, ATCS with additional functions such 
as access to an expert to request advice (ATCS Plus) and multimodal ATCS, where the calls are delivered 
as part of a multi-component intervention, contribute to improve and increase healthcare effects in 
terms of immunisation, screening, and compliance medications and tests[6]. 
 
3. The Cancer Registry is both an organisation and the process to systematically collect, store, analyze, 
interpret and report data of persons suffering from the disease, in order to improve cancer control, and 
evaluate and compare the effects of health policies and practices on this disease. Hospital–based Cancer 
Registries provide readily accessible information on patients with cancer in terms of the treatment they 
receive and the results. Population–based Cancer Registries help gather data and produce statistics on 
cases of cancer concerning a population in a well-delimitated geographical area, providing a framework 
to appreciate and assess an effective cancer control and impact with regards to epidemiological aspects 
which helps define public health priorities, based on etiological studies[7]. Cancer Registries as valuable 
database and information systems should help evaluate the impact of cancer prevention, screening and 
treatment programs, and improve the cancer planning, focusing significantly on the quality of life and 
meeting the needs of patients[8]. 
Ensuring better health care implies prevention, control and measurement as a registration determinant. 
Cancer registration may rely on voluntary or compulsory notification of patients’ outcomes resulting 
from legislation or from an administrative act in virtue of an executive healthcare authority. Designing 
an effective cancer registration service requires the development of appropriate guidelines to protect 
patient confidential data to promote high quality of data and to use those data to benefit patients and 
monitor cancer control advancing medical research[9]. Confidential data permit the identification of an 
individual or patient’s condition. Personal data should be processed lawfully, fairly, in a transparent 
manner in relation to the data subject; collected for specific, explicit and legitimate purposes, adequate, 
relevant and limited to what is necessary, and kept for no longer than necessary, processed in a manner 
that ensures confidentialiy and protection against unauthorised or unlawful processing against 
accidental loss, destruction or damage[10]. The guidelines on confidentiality, in this context, and the 
ethics for Cancer Registries should provide specific measures in order to ensure the preservation of 
personal data[11]. Worldwide guidelines developed since 1991 (IARC[12]) and European guidelines 
(ENCR[13]) developed since 1992 have defined the measures needed to ensure the protection of privacy 
(patients, doctors and the hospitals), specifying which is considered confidential information. Cancer 
Registries should follow the same standards about how to identify and manage confidential data. 
Providing an adequate legal framework helps the effectiveness of the Cancer Registries by ensuring 
privacy to protect the confidentiality of the personal data as the more important threat to cancer 
registration[14],an ethical issue to be considered in terms of completeness and accurateness of registry 
data to minimize risks of loss of privacy and breaches to confidentiality facilitating planning and 
implementation of public health programs and research activities[15]. Regulations and directives 
should help bring together measures for both data and information protection and exchange for 
producing new knowledge and scientific results in terms of therapies, diagnostic and prevention[16]. 
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4. Appreciating cancer survival allows health care providers and policy makers to evaluate the 
effectiveness of health management systems. According to the World Health Organisation (WHO), 16 
million of new cancer cases per year will be by 2020, seventy per cent in developing countries, largely 
resulting from growing environmental pollution and unhealthy eating styles, along with extreme 
working conditions in the exploitation of land natural resources, such as gold, diamonds or petroleum. 
The WHO conducted a study on the frequency and characteristics of latent or overt carcinomas in 
specific body areas, by employing Cancer Registries. Introducing worldwide Cancer Registries for 
comparison data collected helped solve disagreements in diagnosis and increase the effectiveness of 
cancer care and cure[17]. 
Cancer Registries as information management systems should help to improve knowledge and 
information sharing about cancer disease evolution, diagnosis and prevention. It is valuable to consider 
the international experiences and practices in comparison with the organisational form implemented 
for the collection and management of data and information. Cancer Registries help to support strategic 
decision processes regarding complex issues, such as the definition, implementation, and improvement 
of care protocols for diseases, often characterised by incomplete and confused epidemiological data, and 
information about etiology, dynamics and effective treatments with sustainable side effects by patients. 
Cancer Registries collect data and information on all cancers in all residents of a given area (single city, 
entire region, province or nation territory). ‘Specialised’ Cancer Registries collect data and information 
on specific tumours (the colon–rectum, lung, breast, etc.) or on specific age groups (all childhood 
tumours, etc.)[18]. Cancer Registries foster knowledge creation and information management through 
cooperation at inter-organisational levels. Scientific expertise and skills, information technology 
management systems represent strategic resources[19] leading Cancer Registries to be considered as 
decisional support systems helping to learn how to make decisions facing and solving difficult and not 
structured problems[20]. By using flexible data processing systems for advancing scientific and 
organisational learning, and improving the processes for cancer prevention and treatment, the 
knowledge on cancer information management and monitoring proceeding coherently with a double-
loop learning[21]. 
 
 
5. Information on different cases of cancer emerged in the first half of the twentieth century and 
continuously grew over time. Cancer Registries, which originally focused on analysing cancer’s patterns 
and trends on patient survival, developed in order to plan and evaluate activities of cancer control and 
care based on comparability, validity and timeliness of the log data[22]: comparability refers to 
understand a comprehensive review about the registration procedures under place; validity as examined 
through numerical indices; timeliness refers to specific rules for abstraction and register signaling[23]. 
In the 1970s best practices were developed and laid down by national agencies based on detailed 
programmatic criteria (United States, Northern Europe and Japan). In Southern Europe countries, 
Cancer Registries developed in 1990s, as a spontaneous scientific rationale of individual clinicians, 
pathologists, epidemiologists and public health doctors arising from their commitment as physicians, to 
improve the knowledge about the disease and better understanding the causes and mechanisms of 
cancer development[24], in response to significant growth of cancer diseases in the past few decades[25]. 
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Cancer Registries allow professionals to specifically record incidence, mortality and the prevalence of 
cancer. Inequality in cancer prevention and monitoring emerge in low-and middle-income countries 
(LMICs) leading to a continuing cycle of poverty. High-income countries (HICs) mostly have population 
screening programmes (for example, cervix, breast and bowel cancer); however, in LMICs 70% of 
patients do not have access to adequate cancer cures (vaccine, radiotherapy). Socioeconomic status 
tends to influence the possibility of survival. It is necessary to invest in the training of oncologic 
surgeons particularly in LMICs, in acquiring and managing methods to control and prevent the cancer 
by developing adequate population-based cancer registries[26]. The United Nations (UN) has set rules 
to improve global cancer registries adoption to monitor the epidemiological data, which is aimed at 
bridging the clinical and global gap[27]. 
Attention should be paid to the reliability of Cancer Registries in terms of completeness and precision of 
data[28]. For example, while between 1990 and 1996, the Finnish Cancer Registry had recorded, the 
morbidity of 4.922 patients with pancreatic cancer with 89 surviving for at least five years, Carpelan–
Holmström and colleagues[29](2005) showed that the data were inaccurate and only 10 patients 
survived for at least five years. 
It is arguably necessary to effectively plan an active research program tracking records and statistics of 
cancer cases[30]. Some experiences and attempts emerged over time. The EUROPREVAL[31] is a 
European project for studying cancer by highlighting and evaluating the differences between countries, 
in terms of epidemiological evidence and effectiveness of care. EUROPREVAL is based on 38 Cancer 
Registries in 17 European countries, providing data on almost 3 million patients diagnosed with cancer 
between 1970 and 1992. Standardised procedures were used for collecting and validating data by 
identifying large geographical, gender and wealth differences within and among countries. Many types 
of tumours have a higher prevalence in Sweden, Switzerland, Germany and Italy, while showing lower 
trend in Poland, Estonia, Slovenia and Slovakia. Breast cancer accounted for 34% of all women’s 
cancers and colorectal cancer was prevalent in about 15% of males. 
Within richer European countries both a greater presence of cancer cases and a lower number of deaths 
emerge[32]. Introducing and employing Cancer Registries therefore helps achieve positive results in 
terms of improvement in health techniques[33]. Higher levels of cancer survival are shown (Australia, 
Canada and Sweden). Intermediate levels were apparent (Norway) and lowest levels were (Denmark, 
England, Northern Ireland and Wales). 
Analyses tend to check the validity of the cancer registry (Norway, between 2001 and 2005). It has been 
shown that the routines involved were reasonably accurate, close–to–complete and timely[34]. With 
regard to the Sweden, the quality of data provided by the hospitals and the state was confirmed in 
relation to a study of 13,434 cancer patients (1995-2003)[35]. In Japan, a computerised system has 
been developed with the aim of reporting cases of pancreatic cancer[36]. In Iran, Cancer Registries, as 
constructed on regional basis, gathering and collecting data about 3,500 cancer patients, provided 
interesting information[37]. 
 
 
6. In Italy there are no mandatory prescriptions for storing data related to the diagnosis of the cancer 
treatment. The AIRTUM[38] (Associazione Italiana Registro dei Tumori), aims at actively seeking, storing 
and making information available for scientific study and research. The AIRTUM working group (2013) 
showed 4.473 new cases of malignant neoplasie on children and adolescents between 2003 and 2008. 
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The Association of Italian Cancer Registries, established as AIRT in Florence in 1997, aims at 
coordinating the 43 regional Cancer Registries providing data and information on the type of cancer 
diagnosed, the name, address, age and sex of the patient, the clinical conditions, the medical treatments 
and the evolution of the disease with regard for 28 millions patients, corresponding to 47% of the total 
resident population. 
The association through its connection with equivalent bodies in Europe and worldwide supports the 
research, the editorial output and methodological development of various Cancer Registries. 
Since 2006 AIRTUM has aimed to enable the comparison of epidemiological data for cancer between 
the different parts of the country; to survey and measure oncological pathology in terms of mortality, 
incidence and survival; to examine trends over time and to compare the results obtained with those 
observed in other countries. The objectives of the AIRTUM are: to make available to health service 
bodies and the scientific community, data on incidence, mortality, survival and prevalence data for 
tumours in Italy in order to facilitate research, disease prevention and oncologic welfare planning to 
stimulate data analysis so as to shed light on the frequency of cancer in Italy; to contribute to the 
planning of new initiatives in data registration and their evaluation; to foster the standardisation of 
registration techniques; to promote a national and international network; to represent and safeguard, at 
home and abroad, the professional interests of researchers and technical assistants in Italian cancer 
registries; to improve the usage of data registration through guidelines enabling the standardisation of 
results and the setting up of a forum for sharing recent epidemiological research. 
The activities of AIRTUM are focused on establishing a national database for the estimation of 
frequency indicators for cancer in Italy using the information collected from accredited cancer 
registries; to continuously assess the quality of the data collected from associated cancer registries; to 
stimulate, promote and support study and research and conduct the editorial work by disseminating 
publications based on the national database; to organise training courses designed especially for the 
staff of cancer registries; to organise the collection of funds and materials to promote and support 
research activities; to organize seminars and conventions and to collaborate with organisations, bodies, 
institutions and national and international foundations with similar or complementary aims. 
Today, AIRTUM plays a significant role in managing and sharing data and information with regards to 
cancer care. The Italian Health Ministry mandatorily imposed a duty on to public and private hospitals 
to keep all records about the diagnosis and treatment of tumours: the Cancer Registries permit to collect 
information about those sick with cancer resident in a specified area known as population registries, 
and gather data about the tumours of all residents in a specific area which could be a single city, an 
entire region or province, or the area covered by an ASL (Azienda Sanitaria Locale – local public bodies 
providing health services); including data of people affected by a specific type of tumour, 
named specialised registries on a single type of tumour (for example, tumours of the colon, the rectum 
and breasts), or belonging to a specific age group (for example, children aged 0 to 14, and adolescents 
aged 15 to 19). 
The data from Cancer Registries are essential for research about the causes of cancer, the evaluation of 
the efficacy of treatments, the planning of preventive interventions and scheduling expenditure on 
health services. 34 Cancer Registries cover a quarter of the Italian population. The information collected 
includes the type of tumour diagnosed, the name, address, the age and sex of the patient, the clinical 
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circumstances in which the cancer was found, the current treatment and treatment history, and the 
development of the disease[39]. 
Cancer registries collect the data from hospitals, family doctors, local health authorities (ASL), and 
regional health agencies. The main sources are: hospital discharge notesholding a summary of every 
patient admission; anatomical and pathological cytology archives generally ensuring the highest level 
of accuracy of the diagnosis of individual cases following international coding rules with a great 
acquisition of the characteristics of neoplasms (morphology of the cancer, biological structure, grading 
and classification); clinical records disclosing case data that computer processing is often not able to 
achieve, consulted at the hospital, and, rarely, with the treating doctor; along with death certificates all 
accounting for the main sources for information acquisition. 
Cancer Registries are created by the initiative of doctors and professionals operating in the public health 
system. Such initiative is voluntary rather than mandatory. The diffusion of Cancer Registries is not 
homogeneous in Italy. In Southern Italy, there are fewer Cancer Registries (32% in 2013) in comparison 
to North Western (41%), Eastern (69%) and Central Italy (26%). Recently, the Health Ministry 
promoted programmes in order to encourage to extend the registration in all regions of Italy. 
The organisational structure and governance of AIRTUM, as determined in the Statute, is articulated 
in: Members; Organs and Commissions. 
The Members are researchers and technical personnel of Cancer Registries, citizens and people 
interested in health information systems. Members can vote, be elected as officers and participate in all 
the activities of the assembly. 
As for the Organs of the Association: The Assembly of Members (ordinary or extraordinary) is chaired 
by the Secretary and convened at least every year. The ordinary assembly approves the budget and 
annual accounts, discusses and approves a programme of activities and appoints the members of 
the Board of Directors and of the Audit Office. 
The Board of Directors consists of 8 members pro bono, elected by the Assembly before the beginning 
of the year and remaining in charge for two years, potentially re-electable. The Board of Directors is 
responsible for making strategic choices as agreed by the Assembly in terms of designation of 
collaborators, drawing up the budget and annual accounts, presenting an annual report of the 
Association’s scientific endeavour, and convenes the Assembly of Members, appointing delegates for 
workgroups and committees and conducting the business of the Association. The Board of Directors 
elects the Association’s Secretariat and treasurer from among the board members. To accredit a new 
registry, a board meeting may be enlarged to include the directors of all Italian Cancer Registries. 
The Secretariat consists of the Secretary and two Vice-secretaries. The Secretary is the legal 
representative of the Association, responsible for all administrative matters drawing up contracts and 
signing correspondence for and on behalf of the Association. 
The Audit Office, consisting of two members of the Association checks the regular keeping of accounts 
and accounting documentation. 
The Commissions are grouped and specialised for specific matters and affairs (database, financial, 
accreditation, publications, press and web, quality of cancer registries, education, international 
relations). The Commissions have to present an annual programme comprising the objectives and 
activities, the account of the activities performed to be debated and discussed in the annual assembly of 
the Association. 
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The AIRTUM database, available online and periodically hosted by the ISPO (Institute for Oncologic 
Research and Prevention, Florence), is the main national archive on cancer data, collating all tumour 
data, collected by the individual accredited registries. 
There are specific rules that govern the accreditation of a Cancer Registry. The Board for assessment 
appointed by AIRTUM will issue a written judgement within three months of receiving the documents 
and material discussed below. It reserves the right to request further information that, if necessary, will 
be inspected at the offices of the applicant registry. 
The Cancer Registry, to secure accreditation, must submit incidence data covering at least three 
consecutive years, and the production and submission by the applicant registry of complete 
documentation and materials indicated in the AIRTUM Statute. The cases are codified by the individual 
registries following the International Classification of Diseases (ICD-O 3) before being submitted to the 
national database. Their quality is checked before and after being submitted to the database. Analyses of 
quality indicators show a high level of completeness and validity of the collected data, and give 
reassurance of the comparability of the different areas. The high quality of the data produced by 
AIRTUM is suggested by its regular inclusion in international publications on cancer, such as cancer 
incidence or Eurocare 4, Cancer in Five Continents. 
 
7. Many factors, particularly the biological ones and life conditions, affect human health[40]. 
Historically, the Italian region of Campania was known as Campania Felixby virtue of the fertility and 
fruitfulness of its territory[41]. Recently, a large urban and rural area of 1.076 km² and comprising 
more than two million and four thousands of inhabitants (ISTAT, 2013) between the cities of Naples 
and Caserta was negatively renamed by local, national, and international mass media as Terra dei 
Fuochi (Land of Fires) because of toxic and black smoke trails ascending to the sky as a result of the 
incineration of toxic waste burned down along not particularly busy road arteries, and as a territory in 
which criminal economic activities developed by activating an illegal waste cycle that produced large 
scale pollution to the environment[42]. 
The Italian government intervened by identifying 32 municipalities in the province of Naples and 23 
municipalities in the province of Caserta as the Terra dei Fuochi and passing the law n. 6/2014 in 
conversion of the Decree n. 136/2013 in order to solve the so-called waste emergency having a very 
negative impact on public health and the natural environment by the contamination of farmland and 
creating danger for agro-food products within the Campania region. An Inter-Ministerial Committee 
was set up, from which a specific Commission was placed in charge of coordinating a program aimed at 
protecting health, safety, site reclamation and economic revitalization of the territories in question. The 
Campania region was called upon to define the type of examinations for the cancer prevention and the 
control of the health status of the resident population in the municipalities concerned, without any cost 
for patients; it was also determined to update the epidemiological study “Sentieri” by the Higher 
Institute of Health[43]. 
The epidemiological picture of people living in the 55 municipalities of Campania within the Land of 
Fires was characterised by a higher incidence of cancer in for male (11%) and female (9%) compared to 
the national average; the mortality rate for male (9%) and female (7%) tends to exceed the the national 
average according to the data provided by Istituto Superiore della Sanità (2016). 
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As of 2017, there are seven accredited Cancer Registries supplying data and information on 71% of the 
population living in the Campania region, whilst the national average covers only 52% of the population 
of any given region. They are monitoring 20% more of cancer cases in comparison with the Italian 
average, and cover 100% of the cases in the Terra dei Fuochi area, excluding the city of Naples. 
Moreover, the Campania Region is the third Italian region in adopting and obtaining the accreditation 
from AIRTUM of an Infantile Cancer Registry of regional coverage, tracking all new cancer cases 
occurring in the age range of 0–19 years. At present, the Campania Infantile Cancer Registry is the one 
with the highest percentage of supervised children and youngsters in Italy. The AIRTUM has activated 
three Cancer Registries in Naples, Salerno and Caserta. The first two, set up in 1996 and 1997 
respectively, are already part of the AIRTUM network and they are accredited; the Cancer Register in 
Caserta, set up in 2012, is completing its first registration, relating to the data for the 2008-2010 
triennium. In addition, AIRTUM has recently set up the Regional Cancer Registry Network with the aim 
of ensuring, in coming years, a cancer register for each province of Campania region. 
 
 
8. Cancer Registries tend to emerge as important organisational forms for managing data and 
information that support the initiatives and the efforts of public health systems to control, prevent, 
analyse and battle cancer, a disease that slashes people’s lives, while impacting the structure of costs 
and spending within public health systems. 
The Italian experience suggests that AIRTUM as a mechanism of coordination helps Cancer Registries 
better develop important functions and performing the task by strengthening their role and 
contribution. Prevention is typically better, more useful and less costly than providing a cure. Managing 
disease prevention and monitoring helps the development of a public health system and creating 
communities and public awareness on the importance to gather, collect, interpret and analyse data and 
information to anticipate and prevent the negative consequences of cancer. 
New forms of regulatory and formal, international and national governance are arguably necessary to 
discipline the activities of the Cancer Registries so as to effectively fight cancer disease by providing 
useful data, inputs and outputs leading to improved public health policies, while encouraging private 
and public-sector cooperation and collaboration for sustainable economic growth. Bringing together 
voluntary, private initiatives of associations and public programs for sustaining the collecting data, for 
the prevention and monitoring of the disease is seen as a core competence for driving public health 
systems towards greater impact and efficiency. Providing adequate regulatory and organizational 
infrastructure helps improve both information and knowledge management and design and implement 
effective measures and initiatives leading to efficacy in preventing and monitoring cancer disease as 
support to medical scientific research for cancer cure. 
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